Attached files

file filename
EX-31 - EXHIBIT 31.1 - VBI VACCINES INC.ex31-1.htm
EX-32 - EXHIBIT 32.1 - VBI VACCINES INC.ex32-1.htm
EX-31 - EXHIBIT 31.2 - VBI VACCINES INC.ex31-2.htm
EX-99 - EXHIBIT 99.1 - VBI VACCINES INC.ex99-1.htm
EX-10 - EXHIBIT 10.12 - VBI VACCINES INC.ex10-12.htm
EXCEL - IDEA: XBRL DOCUMENT - VBI VACCINES INC.Financial_Report.xls
10-Q - FORM 10-Q - VBI VACCINES INC.vbiv20140930_10q.htm

EXHIBIT 32.2 

  

  

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(b) OR RULE 15d-14(b)

OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350

  

  

  

In connection with the Quarterly Report of VBI Vaccines Inc. (the "Company") on Form 10-Q for the period ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Egidio Nascimento, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

  

          (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

  

          (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

  

  

  

/s/ Egidio Nascimento                               

Egidio Nascimento 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

November 14, 2014

  

This certification is made solely for the purpose of 18 U.S.C. Section 1350, and not for any other purpose. A signed original of this written statement required by Section 906 has been provided to VBI Vaccines Inc. (formerly Paulson Capital (Delaware) Corp.) and will be retained by VBI Vaccines Inc. (formerly Paulson Capital (Delaware) Corp.) and furnished to the Securities and Exchange Commission or its staff upon request.